These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10242286)
1. Informing patients about drugs: a wrong way and a right way. Woodson DW Med World News; 1979 Jun; 20(13):6. PubMed ID: 10242286 [No Abstract] [Full Text] [Related]
3. Regulating off-label drug use--rethinking the role of the FDA. Stafford RS N Engl J Med; 2008 Apr; 358(14):1427-9. PubMed ID: 18385495 [No Abstract] [Full Text] [Related]
4. Developing drug information for patients. Hecht A FDA Consum; 1977 Sep; 11(7):16-9. PubMed ID: 10304999 [No Abstract] [Full Text] [Related]
5. Rx with a dose of info. Miller RW FDA Consum; 1980 Nov; 14(9):22-3. PubMed ID: 10309292 [TBL] [Abstract][Full Text] [Related]
9. Off-label or off-limits? Ratner M; Gura T Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236 [No Abstract] [Full Text] [Related]
10. The status of unit-of-use in Europe and the United States: an evolution in drug dispensing. Archambault GF Hosp Formul; 1979 Jan; 14(1):70-1, 75-6, 78-9. PubMed ID: 10297341 [No Abstract] [Full Text] [Related]
11. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate. Dorfman HL; Quinn VM; Brophy EA Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765 [No Abstract] [Full Text] [Related]
12. Educating patients about their medications: the potential and limitations of written drug information. Shrank WH; Avorn J Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751 [TBL] [Abstract][Full Text] [Related]
13. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691 [TBL] [Abstract][Full Text] [Related]
14. The case for preemption of prescription drug failure-to-warn claims. Kim CH Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969 [No Abstract] [Full Text] [Related]
15. Patient package inserts: the proper prescription? Rowe HM Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988 [No Abstract] [Full Text] [Related]
16. Informing women about 'The Pill'. FDA Consum; 1977 Feb; 11(1):20-1. PubMed ID: 10304983 [No Abstract] [Full Text] [Related]
17. Informing patients on prescription drugs. Hecht A FDA Consum; 1976 Mar; 10(2):4-7. PubMed ID: 828894 [No Abstract] [Full Text] [Related]
19. The right of privacy in choosing medical treatment: should terminally ill persons have access to drugs not yet approved by the Food and Drug Administration? Power SH John Marshall Law Rev; 1987; 20(4):693-714. PubMed ID: 11650094 [No Abstract] [Full Text] [Related]
20. Off-label pharmaceutical use: balancing information, risks, and benefits. Kozma CM Manag Care Interface; 2004 Jan; 17(1):29-30. PubMed ID: 15035597 [No Abstract] [Full Text] [Related] [Next] [New Search]